2022
DOI: 10.1016/j.foodres.2022.111522
|View full text |Cite
|
Sign up to set email alerts
|

Norbixin, a natural dye that improves serum lipid profile in rabbits and prevents LDL oxidation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 62 publications
0
1
0
Order By: Relevance
“…Regarding carotenoid degradation, a similar separation between the different systems as for the oxidative stability could be made, showing the association between oxidative stability and carotenoid degradation. In the oxidatively stable systems, carotenoids were present throughout the storage period, whereas they were absent in the oxidizing systems ( Somacal et al, 2022 ). Moreover, the degradation illustrates the carotenoids’ antioxidative role.…”
Section: Natural Antioxidantsmentioning
confidence: 99%
“…Regarding carotenoid degradation, a similar separation between the different systems as for the oxidative stability could be made, showing the association between oxidative stability and carotenoid degradation. In the oxidatively stable systems, carotenoids were present throughout the storage period, whereas they were absent in the oxidizing systems ( Somacal et al, 2022 ). Moreover, the degradation illustrates the carotenoids’ antioxidative role.…”
Section: Natural Antioxidantsmentioning
confidence: 99%
“…Regarding RQ2, the carotenoid has shown atheroprotective potential, being beneficial in the control of risk factors for atherosclerosis, the main cause of the most common types of cardiovascular disease, as well as in the prevention and treatment of cardiometabolic syndrome (CMetS) (Jebari-Benslaiman et al, 2022;Santos et al, 2002;Somacal et al, 2022). Experimental results have shown that the carotenoid has the potential to act as a PPAR-γ agonist (Goto et al, 2010;Rohini et al, 2018;Wang et al, 2014), a substance of interest for the treatment of CMetS, inhibits the oxidation of human low-density lipoprotein (LDL) in vitro and improves the serum lipid profile in rabbits, increasing the levels of high-density lipoprotein and reducing the levels of triglycerides, autoantibodies, oxidized LDL, atherogenic index, as well as inhibiting lipid and protein oxidation in the aortic tissue of the animals (Somacal et al, 2022), as questioned in RQ3. Another study showed that norbixin inhibits lipid peroxidation, alters plasma lipid levels and paraoxonase/alisterase activities in in vivo tests under conditions of high fat intake, but as noted in RQ4, the doses tested were high and would not be suitable for humans (Santos et al, 2002).…”
Section: Cardiovascular Disease Treatmentmentioning
confidence: 99%